We are live on ! Find out more
BMS

Brummer Multi-Strategy Portfolio holdings

AUM $1.22M
1-Year Est. Return 46.51%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+46.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.5M
AUM Growth
+$11.1M
Cap. Flow
+$11.1M
Cap. Flow %
67.34%
Top 10 Hldgs %
99.85%
Holding
13
New
9
Increased
2
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$3.31M
2
ARVN icon
Arvinas
ARVN
+$1.82M
3
IQV icon
IQVIA
IQV
+$1.78M
4
ABVX
Abivax
ABVX
+$1.57M
5
MRVI icon
Maravai LifeSciences
MRVI
+$1.54M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$1.17M
2
CIGI icon
Colliers International
CIGI
+$691K

Sector Composition

Rank Sector Weight
1 Healthcare 77.93%
2 Real Estate 21.01%
3 Materials 1.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMRK icon
1
Newmark Group
NMRK
$2.87B
$3.48M 21.01%
200,493
+10,974
+6% +$192K
CI icon
2
Cigna
CI
$73.7B
$3.25M 19.66%
+11,818
New +$3.31M
ARVN icon
3
Arvinas
ARVN
$600M
$1.97M 11.93%
+166,342
New +$1.82M
ABVX
4
Abivax
ABVX
$9.89B
$1.94M 11.72%
+14,375
New +$1.57M
IQV icon
5
IQVIA
IQV
$43.1B
$1.84M 11.15%
+8,183
New +$1.78M
MRVI icon
6
Maravai LifeSciences
MRVI
$1.14B
$1.49M 8.99%
+457,707
New +$1.54M
BDX icon
7
Becton Dickinson
BDX
$51.6B
$1M 6.07%
5,176
+4,706
+1,001% +$896K
ATAI icon
8
AtaiBeckley Inc
ATAI
$2.7B
$961K 5.81%
+234,915
New +$1.11M
SLNO
9
DELISTED
Soleno Therapeutics
SLNO
$405K 2.45%
+8,741
New +$479K
GRML
10
Greenland Mines Ltd
GRML
$15.5M
$175K 1.06%
+12,135
New +$291K
FHTX icon
11
Foghorn Therapeutics
FHTX
$356M
$25.4K 0.15%
+4,708
New +$21.3K
CIGI icon
12
Colliers International
CIGI
$5.26B
– –
-4,426
Closed -$691K
PTCT icon
13
PTC Therapeutics
PTCT
$5.85B
– –
-19,142
Closed -$1.17M

Similar funds

DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VS
VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
PCM
Price Capital Management Lafayette, Louisiana $607K AUM 46.82% 1-Year Est. Return

Brummer Multi-Strategy's Q4 2025 Portfolio in Review

As of Q4 2025, Brummer Multi-Strategy held 13 positions worth $16.5M, up 201% from $5.49M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Brummer Multi-Strategy deployed $11.1M of net new capital in Q4 2025, opening 9 new positions and adding to 2 existing holdings. Its largest new stake was Cigna: 11,818 shares worth $3.25M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 23% a quarter earlier, followed by Real Estate and Materials.

On the sell side, the most notable exit was PTC Therapeutics, an estimated $1.17M sold.

  • Brummer Multi-Strategy's largest Q4 2025 buy was Cigna: 11,818 shares worth $3.25M.
  • Brummer Multi-Strategy added most to Becton Dickinson in Q4 2025, an estimated $896K increase.
  • Brummer Multi-Strategy fully exited PTC Therapeutics in Q4 2025, selling an estimated $1.17M.
  • Brummer Multi-Strategy's ten largest holdings make up 100% of its $16.5M portfolio in Q4 2025.
  • Brummer Multi-Strategy opened 9 new positions and closed 2 in Q4 2025.
  • Brummer Multi-Strategy's portfolio value rose 201% quarter-over-quarter to $16.5M.

Based on Brummer Multi-Strategy's 13F filing for Q4 2025, filed 4 Feb 2026.